Clinical trial
This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin…
NCT00380939 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00380939 |
|---|---|
| Title | This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque. |
| Official title | A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Atorvastatin, Pravastatin |
| Enrollment | 600 |
| Start date | Apr 1, 1999 |
| Completion | Dec 1, 2000 |
| First posted | Sep 27, 2006 |
| Last update posted | Dec 4, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: